Latest news with #BioAdaptives
Yahoo
a day ago
- Business
- Yahoo
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
NeuroRush™ delivers a unique blend of adaptogens and nootropic herbs designed to enhance cognitive performance, stress response and long-term brain health, without dependency or burnout. LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), an innovator in evidence-based wellness solutions, today announced the upcoming national release of NeuroRush™, a next-generation nootropic designed to support sustained cognitive performance, mental clarity, and stress adaptability. Following strong results in targeted test markets, NeuroRush™ is scheduled for full commercial release in August/September 2025. Developed as a premium adaptogen-based formula, NeuroRush™ combines six clinically studied ingredients—including Rhodiola Rosea, Ashwagandha, Bacopa Monnieri, Panax Ginseng, and Mucuna Pruriens—to deliver a balanced, non-jittery experience designed for high-functioning individuals. The product will be available in two formulations: one with natural caffeine for fast-acting mental energy, and a caffeine-free version for users sensitive to stimulants. 'We saw exceptional results in controlled launch markets,' said James Keener, CEO of BioAdaptives. 'Customers reported not only better focus and productivity, but also a noticeable improvement in mood, stress control, and cognitive stamina. NeuroRush™ represents our commitment to delivering plant-based performance solutions grounded in science.' NeuroRush™ is formulated to target multiple pathways involved in brain function and stress resilience, making it ideal for professionals, students, athletes, and older adults seeking enhanced mental performance without dependency or crash. The proprietary blend includes adaptogens, neurotransmitter precursors, and nootropic herbs that work synergistically to support dopamine balance, neuroplasticity, and mental endurance. BioAdaptives plans to distribute NeuroRush™ through select online retailers, direct-to-consumer channels, and strategic health & wellness partners nationwide. Initial consumer feedback has highlighted NeuroRush™ as a high-performance solution that stands apart from conventional stimulant-based brain products. About BioAdaptives, Inc. BioAdaptives, Inc. develops and markets science-based natural health and wellness products for both humans and animals. Its formulations leverage cutting-edge research in stem cell biology, adaptogens, and regenerative nutrition. The company's mission is to enhance the quality of life through innovation that works in harmony with the body's natural processes. For more information, visit: Contact:Emily HarrisonInvestor RelationsBioAdaptives, Inc.(702) 659-8829info@ Wire Service Contact:IBNAustin, OfficeEditor@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24-06-2025
- Business
- Yahoo
BioAdaptives Announces National Launch of Pawpa™ Regen
Revolutionary Canine Supplement Promotes Regenerative Healing Through Stem Cell Activation LAS VEGAS , June 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC Pink: BDPT), an innovator in nutraceutical and wellness science, today announces the upcoming national release of Pawpa™ Regen, a proprietary canine supplement that supports natural stem cell activation and regenerative healing in aging dogs. After a successful limited market release earlier this year, Pawpa™ Regen officially launches nationwide at the end of July 2025. This breakthrough formula stimulates the release of circulating stem cells, resulting in improved vitality, responsiveness, mobility, behavior, and appearance in older dogs. 'We've seen extraordinary improvements in energy levels, coat health, mobility and even temperament,' said James Keener, CEO at BioAdaptives. 'Pawpa™ Regen represents a novel approach to canine wellness by tapping into the body's regenerative potential through naturally sourced, safe ingredients.' Pawpa™ Regen's unique mechanism centers on mobilizing endogenous stem cells—a process that supports the repair of tissues, joints, and other systems affected by aging. Dog owners participating in the limited release have reported visible transformation in their pets, including: Increased enthusiasm and alertness Improved gait and movement Brighter eyes and a healthier coat Positive shifts in temperament and sociability 'This is about the quality of life for our aging pets,' said Keener. 'Pawpa™ Regen fills a critical gap in the pet wellness market by delivering cutting-edge science in a safe, accessible, and natural formulation.' The national release will include availability through multiple direct-to-consumer e-commerce platforms. BioAdaptives anticipates strong demand based on early feedback and is scaling production accordingly. With pet owners seeking more holistic, science-based solutions for longevity and vitality, Pawpa™ Regen is poised to become a leading product in the canine wellness and anti-aging segment. About BioAdaptives, Inc. BioAdaptives, Inc. develops and markets science-based natural health and wellness products for both humans and animals. Its formulations leverage cutting-edge research in stem cell biology, adaptogens, and regenerative nutrition. The company's mission is to enhance the quality of life through innovation that works in harmony with the body's natural processes. For more information, visit: Contact: Emily Harrison Investor Relations BioAdaptives, Inc. (702) 659-8829 info@ Wire Service Contact: IBN Austin, Texas 512.354.7000 Office Editor@
